Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Cancer Cell|September 22, 2023
A single-cell atlas of CD19 chimeric antigen receptor T cellsXubin Li, Jared Henderson, Max J Gordon, et al.British Journal of Haematology|June 16, 2025
The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomasRahul Lakhotia, Christopher Melani, Stefania Pittaluga, et al.Blood Neoplasia|June 23, 2025
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignanciesMax J Gordon, Sigrid Dubois, Milos D Miljkovic, et al.Cancer|May 26, 2018
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinibMax J Gordon, Michael Churnetski, Hamood Alqahtani, et al.Blood Advances|March 4, 2026
A phase 1 trial of romidepsin, azacitidine, dexamethasone and lenalidomide in relapsed or refractory T-cell lymphomaMax J Gordon, Milos D Miljkovic, Paige Milhon, et al.Cancer|March 27, 2018
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapyI Brian Greenwell, Ashley D Staton, Michael J Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity ModelMax J Gordon, Andy Kaempf, Andrea Sitlinger, et al.Blood Advances|February 3, 2023
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphomaGeoffrey Shouse, Andy Kaempf, Max J Gordon, et al.Cancer|November 20, 2023
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 studyMax J Gordon, Lei Feng, Paolo Strati, et al.Journal of the National Cancer Institute. Monographs|May 4, 2023
Key takeaways for knowledge expansion of early-career scientists conducting Transdisciplinary Research in Energetics and Cancer (TREC): a report from the TREC Training Workshop 2022Che-Pei Kung, Meghan B Skiba, Erika J Crosby, et al.Pageof 4